Chemical Structure (Meropenem 01)
Meropenem Injection
Product Images NDC 0143-9430
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 0143-9430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (1 g Vial Carton)
The text is not-readable.*
Principal Display Panel (1 g Vial Label)
This text describes a medication with the NDC code 0143-9431-01, which is an IV meropenem solution in a vial containing 1 gram of meropenem activity. Each vial also contains 90.2 mg of sodium. The medication needs to be diluted with an approved diluent for intravenous administration. The storage instructions and manufacturer information are provided. The medication is for intravenous use only and is labeled as a single-dose vial.*
Principal Display Panel (500 mg Vial Carton)
The text mentions information about a medication vial containing Meropenem equivalent to 500 mg of meropenem activity, with sodium content specified. It also includes instructions for dosage and administration via intravenous preparation, dilution, and storage conditions. The product is manufactured by QILU Antibiotics Pharmaceutical Co., Ltd., made for Hikma Pharmaceuticals USA Inc., with a manufacturing date of 07/2024. The details include dosing guidelines, storage conditions, and manufacturing information.*
Principal Display Panel (500 mg Vial Label)
This text is a detailed description of a medication with the NDC number 0143-9430-01. The medication contains Meropenem equivalent to 500 mg of Meropenem activity per vial with a sodium content of 45.1 mg. It is for intravenous use only and should be diluted with an approved diluent as per the Prescribing Information. The medication should be stored at 20°C to 25°C before constitution. It is manufactured by QILU Antibiotics Pharmaceutical Co., Ltd. for Hikma Pharmaceuticals USA Inc. in Berkeley Heights, NJ. The expiration date is shown as YYYY-MMM.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
